CS MEDICA signs agreements with two out of the three leading Danish pharmacy chains.

CS MEDICA A/Ss (“CS MEDICA” or the “Company”) long-awaited breakthrough in the Danish pharmacy world is now a realitywhen they close matches with two from the three leading pharmacy chains in Denmark. With this agreement, the company gains access to: 400 pharmacies in Denmarkwith shelf space as well as online availability for the entire CANNASEN® CBD product line.

Lone HenriksenDIRECTOR CS MEDICA A/S comments

Read:The Danger When Doctors Don’t Get Mental Health Help

“We are proud to announce that we have finally reached pharmacies, signing agreements with two of the three leading pharmacy chains in Denmark. We will leverage and optimize this new position in the market by accelerating our offerings and building branded stores on the growing players within the online pharmacy channel.”

CS MEDICA completed today the cooperation agreement, in voluntary range, with two of the three leading pharmacy chains in Denmark, Pharmaplus and Apotekeren.

Pharmaplus with its 27 main pharmacies and 89 subsidiaries, have agreed to list the entire CANNASEN® CBD product line both in-store and on their web shop.

Read:Researchers develop chicory plants that contain medical compound

apothecary with its 102 main pharmacies and 182 subsidiaries, have agreed to start with the following 4 CANNASEN® CBD products in the store and the full product line on their webshop.

CANNASEN® CBD Psoriasis Gel
CANNASEN® CBD Psoriasis Lotion
CANNASEN® CBD Arthritis Gel
CANNASEN® CBD Anti-Hair Loss Serum

The Danish pharmacists have been a milestone in CS MEDICAs go-to-market strategy, with their innovative CBD products backed by clinical trials, now launching in the Danish market.

To support the training of pharmacies in medical device products with CBD, CS MEDICA has hired a sales consultant with over 20 years of experience in the pharmacy industry.

For more information about CS MEDICAContact us:Lone HenriksenDIRECTOR
Phone: + (45) 71 20 30 47
Email: [email protected]

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to the development, manufacture and commercialization of over-the-counter (OTC) medical device products containing cannabinoids. The company conducts its business through its two wholly-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in Scandinavia, registered distributor of medical devices) and CanNordic A/S (developer and marketer of medical devices (BtB), registered medical device manufacturer). CS MEDICA distributes products across European borders and is headquartered in Copenhagen, Denmark.

Read:Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

The company is listed on Stock market in the spotlight in Stockholm (symbol: “CSMED”). For more information about CS MEDICA,c3618465,c3081155

(c) 2022 Decision. All rights reserved., source Press releases – English

Previous post
Channel crossings to the UK top 25,000 so far this year | Immigration and asylum
Next post
Antonio Conte makes Djed Spence admission ahead of Nottingham Forest vs Tottenham